The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Chimeric Receptors Providing Both Primary and Costimulatory Signaling in T Cells from a Single Gene Product
Abstract
Single chain Fv chimeric receptors, or T-bodies, are described with intracellular sequences comprising the costimulatory signaling domain of CD28 in series with the ζ-chain from the TCR complex. Using an engineered human single chain Fv derived from P67, an mAb with specificity for human CD33, and a spacer comprising an Ab hinge region with either Fcγ or part of the CD28 extracellular region, fusion molecules were constructed to test the ability of single chain designs to mediate both primary signaling and costimulation from one extracellular binding event. Constructs with the CD28 signaling domain proximal and the ζ-chain distal to the membrane were found to express more efficiently in Jurkat than constructs with the opposite orientation and were capable of mediating up to 20 times more IL-2 production on stimulation with solid phase Ag when compared with transfectants expressing chimeric receptors with ζ-chain intracellular signaling domains only. IL-2 production was specific to Ag challenge and was completely inhibited by incubation with free Ab of the same specificity as the extracellular binding site of the construct, but not by an isotype-matched control Ab. The CD28 intracellular domain of these fusion proteins was shown to be capable of binding the p85 subunit of phosphatidylinositol 3′-kinase. These constructs represent the first of a new generation of single gene multidomain chimeric receptors capable of mediating both primary and costimulatory signaling specifically from a single extracellular recognition event.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sequences of proteins of immunological interest
(1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90805-4 · Cited by 3,363
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
Eshhar, Z., Waks, T., Gross, G., & Schindler, D. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.720 · Cited by 1,658
Huston, J. S., Levinson, D., Mudgett-Hunter, M., Tai, M. S., Novotný, J., Margolies, M. N., Ridge, R. J., Bruccoleri, R. E., Haber, E., & Crea, R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.5879 · Cited by 1,593
Gross, G., Waks, T., & Eshhar, Z. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.10024 · Cited by 1,590
Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H., & Allison, J. P. (1992) · Nature · doi:10.1038/356607a0 · Cited by 1,559
Schwartz, R. H. (1992) · Cell · doi:10.1016/s0092-8674(05)80055-8 · Cited by 1,293
Chen, L., Ashe, S., Brady, W. A., Hellström, I., Hellström, K. E., Ledbetter, J. A., McGowan, P., & Linsley, P. S. (1992) · Cell · doi:10.1016/s0092-8674(05)80059-5 · Cited by 1,050
Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system.
Aruffo, A., & Seed, B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8573 · Cited by 784
Janeway, C. A. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.003241 · Cited by 525
Tan, P., Anasetti, C., Hansen, J. A., Melrose, J., Brunvand, M., Bradshaw, J., Ledbetter, J. A., & Linsley, P. S. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.1.165 · Cited by 461
Kuwana, Y., Asakura, Y., Utsunomiya, N., Nakanishi, M., Arata, Y., Itoh, S., Nagase, F., & Kurosawa, Y. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90502-x · Cited by 429
The Biologic Roles Of CD2, CD4, And CD8 In T-Cell Activation
Bierer, B. (1989) · Annual Review of Immunology · doi:10.1146/annurev.immunol.7.1.579 · Cited by 298
Signals through T cell receptor-zeta chain alone are insufficient to prime resting T lymphocytes.
Brocker, T., & Karjalainen, K. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1653 · Cited by 296
In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes.
Hwu, P., Yang, J. C.-H., Cowherd, R., Treisman, J. S., Shafer, G., Eshhar, Z., & Rosenberg, S. A. (1995) · PubMed · Cited by 273
Harding, F. A., & Allison, J. P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.6.1791 · Cited by 265
Andrews, R., Torok-Storb, B., & Bernstein, I. (1983) · Blood · doi:10.1182/blood.v62.1.124.124 · Cited by 257
Hwu, P., Shafer, G. E., Treisman, J., Schindler, D. G., Gross, G., Cowherd, R., Rosenberg, S. A., & Eshhar, Z. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.1.361 · Cited by 256
Upstream-Downstream: CD28 Cosignaling Pathways and T Cell Function
Rudd, C. E. (1996) · Immunity · doi:10.1016/s1074-7613(00)80479-3 · Cited by 225
Targeting of T lymphocytes to Neu/HER2-expressing cells using chimeric single chain Fv receptors.
Stancovski, I., Schindler, D. G., Waks, T., Yarden, Y., Sela, M., & Eshhar, Z. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.11.6577 · Cited by 216
Roberts, M., Qin, L., Zhang, D., Smith, D., Tran, A., Dull, T., Groopman, J., Capon, D., Byrn, R., & Finer, M. (1994) · Blood · doi:10.1182/blood.v84.9.2878.2878 · Cited by 211
Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells.
Moritz, D., Wels, W., Mattern, J., & Groner, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4318 · Cited by 208
Press, O. W., Shan, D., Howell-Clark, J., Eary, J. F., Appelbaum, F. R., Matthews, D. C., King, D. J., Haines, A. M. R., Hamann, P., Hinman, L. M., et al. (1996) · PubMed · Cited by 207
Weissman, A. M., Hou, D., Orloff, D. G., Modi, W. S., Seuanez, H., O'Brien, S. J., & Klausner, R. D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9709 · Cited by 179
Loss of HLA haplotype and B locus down-regulation in melanoma cell lines.
Marincola, F. M., Shamamian, P., Alexander, R. B., Gnarra, J. R., Turetskaya, R. L., Nedospasov, S. A., Simonis, T. B., Taubenberger, J. K., Yannelli, J., Mixon, A., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.3.1225 · Cited by 165
Cure of Xenografted Human Tumors by Bispecific Monoclonal Antibodies and Human T Cells
Renner, C., Jung, W. E., Şahin, U., Denfeld, R. W., Pohl, C., Trümper, L. H. P., Hartmann, F., Diehl, V., van Lier, R. A. W., & Pfreundschuh, M. G. (1994) · Science · doi:10.1126/science.8171337 · Cited by 156
Stein, P. H., Fraser, J. D., & Weiss, A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.3392 · Cited by 150
Álvarez‐Vallina, L., & Hawkins, R. E. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261006 · Cited by 125
Perspectives on the Role of Mhc Antigens in Normal and Malignant Cell Development
Elliott, B. E., Carlow, D. A., Rodricks, A.-M., & Wade, A. (1989) · Advances in cancer research · doi:10.1016/s0065-230x(08)60282-1 · Cited by 121
Vandenberghe, P., Freeman, G. J., Nadler, L. M., Fletcher, M. C., Kamoun, M., Turka, L. A., Ledbetter, J. A., Thompson, C. B., & June, C. H. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.175.4.951 · Cited by 115
New simplified molecular design for functional T cell receptor
Brocker, T., Peter, A., Traunecker, A., & Karjalainen, K. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230705 · Cited by 84
The construction of a highly efficient and versatile set of mammalian expression vectors
Stephens, P. E., & Cockett, M. I. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.17.7110 · Cited by 81
Altenschmidt, U., Kahl, R., Moritz, D. R., Schnierle, B. S., Gerstmayer, B., Wels, W. S., & Groner, B. (1996) · PubMed · Cited by 77
Targeting of peripheral blood T lymphocytes
Bolhuis, R. L. H., Hoogenboom, H. R., & Gratama, J. W. (1996) · Springer Seminars in Immunopathology · doi:10.1007/bf00820667 · Cited by 12
Cited by
The Basic Principles of Chimeric Antigen Receptor Design
Sadelain, M., Brentjens, R., & Rivière, I. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0548 · Cited by 1,535
Milone, M. C., Fish, J. D., Carpenito, C., Carroll, R. G., Binder, G. K., Teachey, D., Samanta, M., Lakhal, M., Gloss, B., Danet-Desnoyers, G., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.83 · Cited by 1,197
Tumor Antigen Escape from CAR T-cell Therapy
Majzner, R. G., & Mackall, C. L. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0442 · Cited by 1,183
Engineered T cells: the promise and challenges of cancer immunotherapy
Fesnak, A. D., June, C. H., & Levine, B. L. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.97 · Cited by 1,074
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor
Maher, J., Brentjens, R. J., Gunset, G., Rivière, I., & Sadelain, M. (2002) · Nature Biotechnology · doi:10.1038/nbt0102-70 · Cited by 1,034
Metadata
- Authors
- Finney, H. M., Lawson, A. D. G., Bebbington, C. R., & Weir, A. N. C.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-09
- Volume
- 161
- Issue
- 6
- Pages
- 2791-2797
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1574443686
- Cited by
- 546
- References
- 34
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.